Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank43
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-87.06M
Near historical average
Percentile
P43
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-80.55M
Historical baseline
PeriodValueYoY Change
2025$-87.06M-0.6%
2024$-86.53M-1.7%
2023$-85.06M+9.4%
2022$-93.91M+24.6%
2021$-124.54M-18.5%
2020$-105.06M-110.6%
2019$-49.88M-303.2%
2018$-12.37M-